vs
Side-by-side financial comparison of Cytosorbents Corp (CTSO) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.
TRANSACT TECHNOLOGIES INC is the larger business by last-quarter revenue ($11.5M vs $9.2M, roughly 1.2× Cytosorbents Corp). On growth, TRANSACT TECHNOLOGIES INC posted the faster year-over-year revenue change (11.9% vs 0.9%). TRANSACT TECHNOLOGIES INC produced more free cash flow last quarter ($589.0K vs $-4.9M). Over the past eight quarters, TRANSACT TECHNOLOGIES INC's revenue compounded faster (3.5% CAGR vs 1.3%).
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
Roper Technologies, Inc. is a holding company that owns companies in the technology sector.
CTSO vs TACT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $11.5M |
| Net Profit | $-5.5M | — |
| Gross Margin | 73.7% | 47.6% |
| Operating Margin | -47.5% | -10.1% |
| Net Margin | -59.5% | — |
| Revenue YoY | 0.9% | 11.9% |
| Net Profit YoY | 27.4% | — |
| EPS (diluted) | $-0.09 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $11.5M | ||
| Q3 25 | $9.5M | $13.2M | ||
| Q2 25 | $9.6M | $13.8M | ||
| Q1 25 | $8.7M | $13.1M | ||
| Q4 24 | $9.2M | $10.2M | ||
| Q3 24 | $8.6M | $10.9M | ||
| Q2 24 | $8.8M | $11.6M | ||
| Q1 24 | $9.0M | $10.7M |
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $-3.2M | $15.0K | ||
| Q2 25 | $1.9M | $-143.0K | ||
| Q1 25 | $-1.5M | $19.0K | ||
| Q4 24 | $-7.6M | — | ||
| Q3 24 | $-2.8M | $-551.0K | ||
| Q2 24 | $-4.3M | $-319.0K | ||
| Q1 24 | $-6.1M | $-1.0M |
| Q4 25 | 73.7% | 47.6% | ||
| Q3 25 | 70.3% | 49.8% | ||
| Q2 25 | 70.9% | 48.2% | ||
| Q1 25 | 71.1% | 48.7% | ||
| Q4 24 | 68.4% | 44.2% | ||
| Q3 24 | 61.0% | 48.1% | ||
| Q2 24 | 73.5% | 52.7% | ||
| Q1 24 | 76.5% | 52.6% |
| Q4 25 | -47.5% | -10.1% | ||
| Q3 25 | -30.2% | 0.1% | ||
| Q2 25 | -37.6% | -1.9% | ||
| Q1 25 | -44.5% | -0.1% | ||
| Q4 24 | -37.1% | -10.3% | ||
| Q3 24 | -56.1% | -7.7% | ||
| Q2 24 | -40.4% | -3.8% | ||
| Q1 24 | -51.8% | -12.2% |
| Q4 25 | -59.5% | — | ||
| Q3 25 | -33.4% | 0.1% | ||
| Q2 25 | 20.2% | -1.0% | ||
| Q1 25 | -16.9% | 0.1% | ||
| Q4 24 | -82.7% | — | ||
| Q3 24 | -32.1% | -5.1% | ||
| Q2 24 | -48.6% | -2.8% | ||
| Q1 24 | -67.7% | -9.7% |
| Q4 25 | $-0.09 | $-0.11 | ||
| Q3 25 | $-0.05 | $0.00 | ||
| Q2 25 | $0.03 | $-0.01 | ||
| Q1 25 | $-0.02 | $0.00 | ||
| Q4 24 | $-0.14 | $-0.80 | ||
| Q3 24 | $-0.05 | $-0.06 | ||
| Q2 24 | $-0.08 | $-0.03 | ||
| Q1 24 | $-0.11 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.2M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.9M | $31.1M |
| Total Assets | $44.2M | $44.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.2M | $20.4M | ||
| Q3 25 | $7.5M | $20.0M | ||
| Q2 25 | $10.2M | $17.7M | ||
| Q1 25 | $11.6M | $14.2M | ||
| Q4 24 | $3.3M | $14.4M | ||
| Q3 24 | $5.7M | $11.3M | ||
| Q2 24 | $8.5M | $11.1M | ||
| Q1 24 | $8.6M | $10.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.8M | — | ||
| Q2 24 | $13.7M | — | ||
| Q1 24 | $4.4M | — |
| Q4 25 | $5.9M | $31.1M | ||
| Q3 25 | $9.0M | $31.8M | ||
| Q2 25 | $11.6M | $31.3M | ||
| Q1 25 | $14.5M | $30.9M | ||
| Q4 24 | $11.1M | $30.6M | ||
| Q3 24 | $13.4M | $38.4M | ||
| Q2 24 | $17.4M | $38.5M | ||
| Q1 24 | $19.6M | $38.6M |
| Q4 25 | $44.2M | $44.8M | ||
| Q3 25 | $45.8M | $45.0M | ||
| Q2 25 | $48.0M | $44.5M | ||
| Q1 25 | $50.8M | $44.2M | ||
| Q4 24 | $47.4M | $44.0M | ||
| Q3 24 | $47.8M | $50.5M | ||
| Q2 24 | $53.4M | $50.4M | ||
| Q1 24 | $47.1M | $51.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.23× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.8M | $609.0K |
| Free Cash FlowOCF − Capex | $-4.9M | $589.0K |
| FCF MarginFCF / Revenue | -53.4% | 5.1% |
| Capex IntensityCapex / Revenue | 1.2% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | $7.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.8M | $609.0K | ||
| Q3 25 | $-2.6M | $3.6M | ||
| Q2 25 | $-1.5M | $3.6M | ||
| Q1 25 | $-3.5M | $-161.0K | ||
| Q4 24 | $-2.3M | $2.4M | ||
| Q3 24 | $-2.5M | $327.0K | ||
| Q2 24 | $-4.8M | $636.0K | ||
| Q1 24 | $-4.8M | $-1.5M |
| Q4 25 | $-4.9M | $589.0K | ||
| Q3 25 | $-2.6M | $3.6M | ||
| Q2 25 | $-1.5M | $3.6M | ||
| Q1 25 | $-3.5M | $-171.0K | ||
| Q4 24 | $-2.4M | $2.4M | ||
| Q3 24 | $-2.6M | $259.0K | ||
| Q2 24 | $-4.8M | $499.0K | ||
| Q1 24 | $-4.9M | $-1.6M |
| Q4 25 | -53.4% | 5.1% | ||
| Q3 25 | -27.3% | 27.1% | ||
| Q2 25 | -16.1% | 25.9% | ||
| Q1 25 | -39.7% | -1.3% | ||
| Q4 24 | -26.3% | 23.2% | ||
| Q3 24 | -30.4% | 2.4% | ||
| Q2 24 | -54.4% | 4.3% | ||
| Q1 24 | -54.2% | -14.9% |
| Q4 25 | 1.2% | 0.2% | ||
| Q3 25 | 0.2% | 0.5% | ||
| Q2 25 | 0.4% | 0.1% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.8% | 0.1% | ||
| Q3 24 | 1.8% | 0.6% | ||
| Q2 24 | 0.2% | 1.2% | ||
| Q1 24 | 0.5% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | -0.78× | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
TACT
Segment breakdown not available.
